Mass.gov
    
Mass.Gov home Mass.gov  home get things done agencies Search Mass.Gov
Massachusetts Department of Public Health
Go to DPH Home Skip Navigation

Bureau of Communicable Disease Control Logo
Bureau of Communicable Disease Control

*HIV/AIDS Surveillance
*Epidemiology & Immunization
*Tuberculosis Prevention & Control
*STD Prevention
*Refugee & Immigrant Health

Related Sites
*Centers for Disease Control

Contact Information

Division of Epidemiology and Immunization
State Laboratory Institute
305 South Street
Jamaica Plain, MA 02130

Tel.(617) 983-6800
Fax(617) 983-6840

Search the DPH Website
Tick-Borne Diseases of Massachusetts, 2000

Tick-Borne Diseases Of Massachusetts, 2000

An Update For Health Care Providers
Massachusetts Department of Public Health
Division of Epidemiology and Immunization
February 2000


I. Four tick-borne diseases endemic to coastal Massachusetts: Human Granulocytic Ehrlichiosis (HGE), Rocky Mountain Spotted Fever  (RMSF), Babesiosis, Tularemia
 

  • All of these diseases are of low frequency; all can cause life-threatening illness.

  • HGE and babesiosis are transmitted primarily by the tiny deer tick, Ixodes scapularis.  RMSF is transmitted by the common dog tick, Dermacentor variabilis. Tularemia is transmitted by both. 

  • Coinfection of Ixodes scapularis with two or more of these human pathogens has been reported and may be responsible for more severe variants of these tick-borne diseases.

  • Since residents from all areas of Massachusetts travel to coastal Massachusetts, and infected individuals may not show clinical signs until they have returned to their homes in other parts of the state, taking a complete travel history is essential when considering many infectious diseases.

  • The tick vectors of these infectious agents are widely distributed throughout the state, and the infections may spread to central and western parts of Massachusetts, as has happened with Lyme disease. (Lyme disease is covered under a separate update.)

  • The greatest risk of infection with any of these agents is from April through August, when ticks are most active.

 II.  Reporting

  • Rocky Mountain spotted fever, babesiosis, and tularemia are reportable by law to the local board of health or the Massachusetts Department of Public Health (MDPH).
  • Although human granulocytic ehrlichiosis (HGE) is not yet reportable by law, to assist us in accurately estimating the prevalence of this disease, the MDPH encourages direct reporting of this disease to the MDPH Division of Epidemiology and Immunization at (617) 983-6800.  It is believed that cases of HGE are currently significantly underestimated.

 III.  Summary of clinical symptoms, incidence, and etiology

  • Human Granulocytic Ehrlichiosis (HGE)

    HGE, an acute febrile illness caused by an agent similar or identical to the veterinary pathogens Ehrilichia equi and Ehrilichia phagocytophila, can be mistaken for a rashless Lyme disease or babesiosis, especially when associated with a history of tick attachment. Since its discovery in 1993, over 449 cases of HGE have been collected by the Centers for Disease Control and Prevention (CDC).  To date, 10 confirmed cases of HGE have been identified in Massachusetts; the majority of cases occurred in tick-exposed residents of Cape Cod and the surrounding islands.  Clinical features of HGE include fever, headache, malaise, myalgia, chills, sweats, nausea, and vomiting.  Cough, arthralgia, confusion, and a macular or papular rash at any site on the body occur, but are less common.  Laboratory findings commonly include leukopenia, thrombocytopenia, and elevated liver function tests.  HGE is treatable with doxycycline and other tetracyclines.  The effectiveness of chloramphenicol, preferred by many physicians for use in younger children, remains controversial.  As HGE may progress swiftly to become life-threatening, it is critical to begin treatment for HGE as soon as the diagnosis is strongly suspected (even prior to laboratory confirmation).

  • Rocky Mountain spotted fever (RMSF)

    RMSF, caused by the bacterium Rickettsia rickettsii, is a systemic, febrile illness with a characteristic rash that usually occurs before the sixth day of illness.  Frequently described clinical features include fever, headache, myalgia, toxicity, malaise, and nausea or vomiting, with abdominal pain and cough being noted less frequently.  The rash first appears more than 48 hours after the onset of illness on the extremities and then spreads proximally to the trunk; there is often involvement of the palms and soles.  However, the rash is not a universal feature of the illness.  Prompt recognition and treatment of RMSF are important as the disease can be fatal.  RMSF is most often reported from Cape Cod and the surrounding islands, although some cases have occurred in central Massachusetts.  One confirmed case of RMSF was reported in 1999, with no cases in 1998 or 1997, two cases in 1996, one in 1995, four cases in each of 1994 and 1993, three cases in 1992, 4 cases in 1991 and 15 in 1990. 

  • Babesiosis

    Babesiosis, caused by the parasite Babesia microti, resembles malaria.  Persons who are asplenic are particularly susceptible to symptomatic babesiosis and more severe disease.  It is typically characterized by a gradual onset of malaise, anorexia and fatigue, followed by intermittent fever (as high as 104oF) and one or more of the following: chills, sweats, myalgia, arthralgia, nausea or vomiting.  There were 41 confirmed cases of babesiosis reported in Massachusetts in 1999, 65 cases in 1998, 20 cases in 1997, 20 cases in 1996, 13 cases in 1995, 15 cases in 1994, 6 in 1993, 14 in 1992, 9 in 1991 and 3 in 1990.  Babesiosis is diagnosed by observing the parasite in red blood cells on thick and thin blood smears with Giemsa solution.  A serologic antibody test is now available at the Centers for Disease Control and Prevention (See Section IV).

  • Tularemia

    Tularemia, caused by the bacterium Francisella tularensis, is usually characterized by high fever and severe, influenza-like constitutional symptoms of chills, myalgia, and headache.  The incubation period averages 3 to 5 days, but can be as long as 21 days.  Although the infection is commonly acquired from ticks, it can be acquired by inhalation, ingestion of contaminated water or undercooked meat, or direct contact with infected animals.  Depending on the mode of transmission, the patient may have one of several tularemic syndromes, including the ulceroglandular, oculoglandular, oropharyngeal, glandular, typhoidal, or pneumonic syndromes.  Over 100 species of wild and domestic animals are susceptible, including rabbits, squirrels, deer, cats, and cattle.  In Massachusetts, major reservoirs of tularemia include ticks and rabbits. There were 5 confirmed cases of tularemia reported in Massachusetts in 1999, 3 cases in 1998, 1 case each in 1996, 1994, and 1992, 5 cases in 1991, 4 cases in 1990 and no cases in 1993, 1995, and 1997. Streptomycin for 6 to 10 days is the usual therapy for infected persons, and gentamicin also appears effective.  Bacteriostatic antibiotics, such as tetracyclines and chloramphenicol, have been associated with treatment failure and relapse.  A fourfold or greater rise in the serum F. tularensis agglutinin titer frequently is evident after the second week of illness and is considered diagnostic.  A single convalescent titer of 1:160 or greater is consistent with recent or past infection.  In rare cases of acute illness where the patient may not yet have developed antibodies, physicians may want to culture specimens (biopsy, aspirate, bone marrow) for F. tularensis.

IV. Testing

 The Viral Serology Laboratory at the State Laboratory Institute (SLI), Massachusetts Department of Public Health (MDPH), 305 South Street, Jamaica Plain, MA 02130, provides free serologic testing for RMSF (R. ricketsii).  Samples for serology should be sent to the above address.  For HGE and babesiosis, sera should be sent to the MDPH Viral Serology Laboratory, which will then forward it to the CDC for testing.  For tularemia, the MDPH Enterics Laboratory provides free serologic testing.  Samples should be sent to Room 406 or 407, MDPH, 305 South Street, Jamaica Plain, MA  02130.  Physicians wishing to have specimens cultured for F. tularensis should call the MDPH Reference Laboratory at 617-983-6607.

For additional information about prevention and epidemiology, contact:

Division of Epidemiology and Immunization, MDPH                                     617-983-6800

For information about submitting specimens to the SLI, contact:                                

Viral Serology Laboratory, MDPH
Enterics Laboratory, MDPH  
Reference Laboratory, MDPH 
617-983-6396
617-983-6609
617-983-6607

 


Please note: PDF files can be viewed with Adobe’s free Acrobat Reader. For assistance viewing PDF files, please go to Massachusetts' PDF page. Microsoft Word, Excel, and PowerPoint files can be viewed with Microsoft’s free viewers. If you need DPH files in an alternate format, please contact us.

DPH Homepage | What's New | Health Topics A-Z | Programs | Publications/Statistics | Directory | For Providers | In The Press | Related WWW Sites | Employment

© 2002 The Massachusetts Department of Public Health                    Privacy Policy   Contact Us
Go back to DPH Home